Share This Page
Drug Price Trends for NDC 00093-8076
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-8076
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TIAGABINE HCL 16 MG TABLET | 00093-8076-56 | 6.02680 | EACH | 2025-04-23 |
| TIAGABINE HCL 16 MG TABLET | 00093-8076-56 | 6.25781 | EACH | 2025-03-19 |
| TIAGABINE HCL 16 MG TABLET | 00093-8076-56 | 6.48883 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-8076
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 00093-8076
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a drug identified by the NDC 00093-8076, it is crucial to first understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code, providing detailed information about the drug product, its manufacturer, and packaging[5].
Market Analysis
Generic vs. Branded Drugs
If the drug corresponding to NDC 00093-8076 is a generic drug, it operates within the commodity-like generic drug industry. This sector is characterized by mid-single-digit percent annual price erosion and modest revenue growth. Generic drugs face intense competition, which can limit profitability despite substantial revenue growth[2].
Pricing Dynamics
Pricing for generic drugs, such as the one identified by NDC 00093-8076, is influenced by several factors:
- Competition: The presence of multiple generic versions of the same drug can drive prices down.
- Regulatory Environment: FDA inspections and potential price-fixing litigation can impact pricing strategies.
- Market Demand: The demand for the drug, driven by factors such as the prevalence of the condition it treats, can influence pricing[2].
Current Pricing Trends
In the generic drug market, prices are expected to erode annually by mid-single-digit percentages. This trend is consistent with the current outlook for the pharmaceutical industry, where revenue growth is modest but stable.
Example Scenario
If the drug corresponding to NDC 00093-8076 is priced at $100 per unit currently, here is a possible price projection over the next few years:
| Year | Price per Unit |
|---|---|
| 2024 | $100 |
| 2025 | $95 |
| 2026 | $90.25 |
| 2027 | $85.74 |
| 2028 | $81.36 |
This scenario assumes an annual price erosion of about 5%, which is within the expected range for generic drugs[2].
Future Pricing Projections
Annual Price Erosion
Expect prices to decrease by around 3-5% annually due to market competition and regulatory pressures. This erosion is a common trend in the generic drug market, where multiple competitors drive down prices to maintain market share[2].
Revenue Growth
Despite price erosion, the overall revenue for generic drugs may still grow modestly due to increased volume and market penetration. As more patients opt for generic versions of drugs, the total sales volume can increase, compensating for the decrease in price per unit[2].
Cost Recovery
Companies will need to balance their pricing to cover costs, including distribution, marketing (if applicable), and earning a reasonable return on investment. This balance is crucial for maintaining profitability in a highly competitive market[2].
Distribution and Marketing
The distribution and marketing strategies for the drug can also influence its pricing. For instance, if the company does not engage in direct-to-consumer marketing or paid advertising, costs can be kept lower, allowing for more competitive pricing. This approach is seen in companies like Dr. Reddy’s Laboratories, which introduced a generic version of Lenalidomide with a significant price reduction compared to the branded version, Revlimid[2].
Regulatory Environment
The regulatory environment plays a significant role in pricing strategies. FDA inspections and potential litigation related to price-fixing can impact how companies set their prices. Ensuring compliance with FDA regulations is crucial for maintaining market presence and avoiding legal repercussions[2].
Market Demand
Increasing demand for drugs treating chronic conditions can support higher sales volumes. For example, drugs used to treat conditions like diabetes, obesity, and related health issues are in high demand, which can help offset the effects of price erosion[3].
Global Pricing Comparisons
The pricing of drugs in the U.S. is significantly higher compared to other regions. According to ASPE, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.) in 2022. This disparity highlights the unique pricing dynamics in the U.S. market[4].
Impact of Industry Trends
Patent Cliff and Generic Competition
The life sciences industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products. This trend is expected to drive interest in mergers and acquisitions and increase competition from generic drugs and biosimilars. Nearly half of the C-suite executives surveyed by Deloitte expect pricing and access to drugs to significantly affect their strategies in 2025[3].
Digital Transformation and Innovation
The integration of technologies like AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations. This digital transformation can lead to more precise treatment options, such as personalized medicine, which can improve patient outcomes and reduce side effects[3].
NDC Format Changes
The FDA is considering changes to the NDC format due to the depletion of current NDC numbers. This change will impact nearly every system in the pharmaceutical supply chain and pharmacy operations. The transition from a 5-digit labeler code to a 6-digit labeler code will have significant business, economic, IT, and clinical practice impacts, similar to the Y2K transition in the pharmacy sector[1].
Key Takeaways
- Pricing Trends: Expect annual price erosion in the range of 3-5% due to market competition.
- Revenue Growth: Modest revenue growth is anticipated despite price erosion.
- Cost Management: Companies must balance pricing to cover costs and earn a reasonable return on investment.
- Regulatory Compliance: Ensuring compliance with FDA regulations is crucial for maintaining market presence.
- Market Demand: Increasing demand for drugs treating chronic conditions can support higher sales volumes.
FAQs
Q: What is the National Drug Code (NDC) and how is it structured?
The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and package code of a drug. It is structured into a labeler code, product code, and package code, providing detailed information about the drug product, its manufacturer, and packaging[5].
Q: Why do generic drug prices tend to erode over time?
Generic drug prices tend to erode due to intense competition from multiple generic versions of the same drug, regulatory pressures, and market demand dynamics[2].
Q: How does the regulatory environment impact drug pricing?
The regulatory environment, including FDA inspections and potential litigation related to price-fixing, can significantly impact how companies set their prices and maintain market presence[2].
Q: What are the implications of the FDA's potential changes to the NDC format?
The transition to a new NDC format will impact nearly every system in the pharmaceutical supply chain and pharmacy operations, requiring significant updates and recoding of systems over the next decade and beyond[1].
Q: How does global pricing compare for drugs in the U.S. versus other regions?
The average price per unit in the U.S. is significantly higher compared to other regions, being 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.) in 2022[4].
Sources
- Wolters Kluwer: "Are You Prepared for a Major Industry Change to the National Drug Code (NDC) Number?"
- DrugPatentWatch: "Latest drug prices and trends for NDC 00093-7664"
- Deloitte Insights: "2025 life sciences outlook"
- ASPE: "International Market Size and Prices"
- FDA: "National Drug Code Database Background Information"
More… ↓
